---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-024913"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2026-05-22T12:00:37+00:00"
generated_at: "2026-05-22T12:09:06.668846+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma receives Nasdaq extension to Nov 16, 2026 to meet $1 minimum bid price

## Summary
- Received Nasdaq Staff letter on May 20, 2026 granting 180-day extension until Nov 16, 2026 for minimum bid price compliance.
- Previously received initial deficiency notice on Nov 20, 2025; initial 180-day period expired May 19, 2026.
- Company meets all other Nasdaq Capital Market initial listing requirements except for minimum bid price.
- No assurance of compliance; company will monitor bid price and assess options to regain compliance.

## SEC filing metadata
- accession: 0001493152-26-024913
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2026-05-22T12:00:37+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000149315226024913/0001493152-26-024913-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000149315226024913/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-024913
- JSON: https://secwatch.observer/filing/0001493152-26-024913.json
- Plain text: https://secwatch.observer/filing/0001493152-26-024913.txt

## Source-grounded claims
- claim_id: f3e91a8366d603256662576fcb1ae6f193640bd2
  claim: GT Biopharma, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(H)).
  evidence_excerpt: May 20, 2026, GT Biopharma, Inc., a Delaware corporation (the “Company”), received a letter from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that
  evidence_url: https://www.sec.gov/Archives/edgar/data/109657/000149315226024913/0001493152-26-024913-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.